UK Genomics Roundtable 1 – Cancer early detection and surveillance, the role of the liquid biopsy
Cancer early detection and surveillance, the role of the liquid biopsy
Chair: Dr Jacqui Shaw, Professor of Translational Cancer, University of Leicester
The advances in genomics and whole genome sequencing at scale are now revealing the true extent of human genomic variation including the cancer genome. Liquid biopsy, notably circulating tumour DNA (ctDNA) is a clinical tool to support earlier detection of cancer, surveillance, and personalised medicine approaches.
Our response to the pandemic has showcased the rapid developments the scientific community can deliver when it is brought together. We need to apply the same scientific endeavour to exploit the clinical potential of liquid biopsies. This expert group is being assembled by Public Policy Projects to prepare an authoritative report that may inform Government, academia, industry and funding bodies planning and strategy. This group will consider the key features and infrastructure required to develop and deliver a world-leading national early detection and monitoring strategy to include.
- Cancer and Cell Free (session 1) – Chair: Jacqui Shaw – Tue 11 May 11:00am-12:30pm Register HERE
- 11 May, 2021 11:00 - 12:30 BST
- Virtual, Zoom webinar See map